Sartorius (FRA:SRT3) has been assigned a €85.00 ($101.19) price objective by research analysts at Berenberg Bank in a research report issued on Wednesday. The firm presently has a “buy” rating on the stock. Berenberg Bank’s price target indicates a potential upside of 6.74% from the stock’s current price.
A number of other research analysts have also issued reports on SRT3. Commerzbank set a €87.00 ($103.57) target price on shares of Sartorius and gave the company a “neutral” rating in a research note on Wednesday, September 13th. Deutsche Bank set a €88.00 ($104.76) target price on shares of Sartorius and gave the company a “neutral” rating in a research note on Tuesday, October 17th. Oddo Bhf set a €72.00 ($85.71) target price on shares of Sartorius and gave the company a “sell” rating in a research note on Tuesday, October 17th. Warburg Research set a €100.00 ($119.05) price target on shares of Sartorius and gave the stock a “buy” rating in a research note on Tuesday, October 17th. Finally, Kepler Capital Markets set a €64.00 ($76.19) price target on shares of Sartorius and gave the stock a “neutral” rating in a research note on Tuesday, October 17th. Three investment analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of €77.00 ($91.67).
Sartorius (FRA SRT3) traded up €0.10 ($0.12) during trading on Wednesday, reaching €79.63 ($94.80). 48,635 shares of the company’s stock were exchanged. Sartorius has a 52-week low of €63.72 ($75.86) and a 52-week high of €94.00 ($111.90).
TRADEMARK VIOLATION WARNING: This piece of content was originally published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The correct version of this piece of content can be accessed at https://ledgergazette.com/2017/12/06/sartorius-srt3-given-a-85-00-price-target-at-berenberg-bank.html.
Sartorius Aktiengesellschaft provides laboratory and process technologies and equipment worldwide. The company operates through two divisions, Bioprocess Solutions, and Lab Products & Services. The Bioprocess Solutions division offers products, technologies, and services ranging from fermentation, cell cultivation, filtration, and purification to media storage and transportation for the biopharmaceutical industry.
Receive News & Ratings for Sartorius AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius AG and related companies with MarketBeat.com's FREE daily email newsletter.